18 May 2013
Keywords: amarillo, bio, commercialize, low-dose, interferon, se, asia
Article | 05 December 2005
Texas, USA-based Amarillo Biosciences says that it has entered into an agency agreement with Claus Martin, chief executive of Gesellschaft ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 December 2005
12 December 2005
17 May 2013
© 2013 thepharmaletter.com